Feres C Maluf, William A Pace, Lynn Leng, Pablo Suarez, Darren Chau, Udaybir Mann, Maria C Velasquez, Kazumi Taguchi, Joel T Funk, James E Bryant, Karishma Gupta, Thomas Chi
{"title":"良性前列腺增生钬激光摘除前列腺后膀胱容量和空腔残留预测尿失禁。","authors":"Feres C Maluf, William A Pace, Lynn Leng, Pablo Suarez, Darren Chau, Udaybir Mann, Maria C Velasquez, Kazumi Taguchi, Joel T Funk, James E Bryant, Karishma Gupta, Thomas Chi","doi":"10.1016/j.urology.2025.09.049","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To better understand and potentially predict transient urinary incontinence (TUI) following Holmium laser enucleation of the prostate (HoLEP), we investigated whether preoperative urodynamic studies (UDS), the gold standard for assessing bladder physiology, can identify patients at higher risk for TUI.</p><p><strong>Methods: </strong>We conducted a single-institution retrospective cohort study of patients who underwent UDS followed by HoLEP for BPH between 2017 and 2023. We collected data on baseline characteristics, UDS parameters, and perioperative outcomes. The primary outcome was urinary incontinence (UI) at 1, 3, 6, and 12 months post-surgery.</p><p><strong>Results: </strong>129 subjects were identified and univariate analysis demonstrated that post-operative UI rates were lower in patients with a preoperative post-void residual (PVR) greater than 250mL when compared to those with a PVR ≤250mL at 3 months (33.3% vs. 55.6%;p=0.02) and 6 months (11.5% vs. 39.2%;p<0.01). Similarly, patients with a bladder capacity exceeding 600mL experienced lower UI rates at 1 month (p=0.01), 6 months (p<0.01), and 12 months (p=0.03) compared to those with a bladder capacity ≤600mL. Furthermore, adjusted analysis confirmed these findings that PVR >250mL and bladder capacity >600mL were associated with a 28% (95%CI [12.1%-43.3%];p<0.01) and 26% (95%CI [13.2%-39%];p<0.01) lower probability of UI at 6 months, respectively.</p><p><strong>Conclusions: </strong>Adding baseline PVR and bladder capacity assessment to the preoperative evaluation may supplement counseling on protective factors for UI following HoLEP.</p>","PeriodicalId":23415,"journal":{"name":"Urology","volume":" ","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2025-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"\\\"Post Void Residual and Bladder Capacity Predict Urinary Continence Following Holmium Laser Enucleation of the Prostate for Benign Prostatic Hyperplasia\\\".\",\"authors\":\"Feres C Maluf, William A Pace, Lynn Leng, Pablo Suarez, Darren Chau, Udaybir Mann, Maria C Velasquez, Kazumi Taguchi, Joel T Funk, James E Bryant, Karishma Gupta, Thomas Chi\",\"doi\":\"10.1016/j.urology.2025.09.049\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>To better understand and potentially predict transient urinary incontinence (TUI) following Holmium laser enucleation of the prostate (HoLEP), we investigated whether preoperative urodynamic studies (UDS), the gold standard for assessing bladder physiology, can identify patients at higher risk for TUI.</p><p><strong>Methods: </strong>We conducted a single-institution retrospective cohort study of patients who underwent UDS followed by HoLEP for BPH between 2017 and 2023. We collected data on baseline characteristics, UDS parameters, and perioperative outcomes. The primary outcome was urinary incontinence (UI) at 1, 3, 6, and 12 months post-surgery.</p><p><strong>Results: </strong>129 subjects were identified and univariate analysis demonstrated that post-operative UI rates were lower in patients with a preoperative post-void residual (PVR) greater than 250mL when compared to those with a PVR ≤250mL at 3 months (33.3% vs. 55.6%;p=0.02) and 6 months (11.5% vs. 39.2%;p<0.01). Similarly, patients with a bladder capacity exceeding 600mL experienced lower UI rates at 1 month (p=0.01), 6 months (p<0.01), and 12 months (p=0.03) compared to those with a bladder capacity ≤600mL. Furthermore, adjusted analysis confirmed these findings that PVR >250mL and bladder capacity >600mL were associated with a 28% (95%CI [12.1%-43.3%];p<0.01) and 26% (95%CI [13.2%-39%];p<0.01) lower probability of UI at 6 months, respectively.</p><p><strong>Conclusions: </strong>Adding baseline PVR and bladder capacity assessment to the preoperative evaluation may supplement counseling on protective factors for UI following HoLEP.</p>\",\"PeriodicalId\":23415,\"journal\":{\"name\":\"Urology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2025-10-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Urology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.urology.2025.09.049\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.urology.2025.09.049","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
摘要
目的:为了更好地了解和潜在地预测钬激光前列腺摘除(HoLEP)后的一过性尿失禁(TUI),我们研究了术前尿动力学研究(UDS)——评估膀胱生理的金标准——是否能识别出TUI的高风险患者。方法:我们对2017年至2023年间接受UDS和HoLEP治疗BPH的患者进行了一项单机构回顾性队列研究。我们收集了基线特征、UDS参数和围手术期结果的数据。主要结局是术后1、3、6和12个月的尿失禁(UI)。结果:129名受试者被确定,单因素分析显示,术前空腔残留(PVR)大于250mL的患者术后尿失尿率低于术前空腔残留≤250mL的患者(33.3% vs. 55.6%, p=0.02)和术前空腔残留≤250mL的患者(11.5% vs. 39.2%), p250mL和膀胱容量bb0 600mL与尿失尿率相关28% (95%CI [12.1%-43.3%];结论:在术前评估中加入基线PVR和膀胱容量评估可以补充HoLEP术后尿失禁的保护因素咨询。
"Post Void Residual and Bladder Capacity Predict Urinary Continence Following Holmium Laser Enucleation of the Prostate for Benign Prostatic Hyperplasia".
Objectives: To better understand and potentially predict transient urinary incontinence (TUI) following Holmium laser enucleation of the prostate (HoLEP), we investigated whether preoperative urodynamic studies (UDS), the gold standard for assessing bladder physiology, can identify patients at higher risk for TUI.
Methods: We conducted a single-institution retrospective cohort study of patients who underwent UDS followed by HoLEP for BPH between 2017 and 2023. We collected data on baseline characteristics, UDS parameters, and perioperative outcomes. The primary outcome was urinary incontinence (UI) at 1, 3, 6, and 12 months post-surgery.
Results: 129 subjects were identified and univariate analysis demonstrated that post-operative UI rates were lower in patients with a preoperative post-void residual (PVR) greater than 250mL when compared to those with a PVR ≤250mL at 3 months (33.3% vs. 55.6%;p=0.02) and 6 months (11.5% vs. 39.2%;p<0.01). Similarly, patients with a bladder capacity exceeding 600mL experienced lower UI rates at 1 month (p=0.01), 6 months (p<0.01), and 12 months (p=0.03) compared to those with a bladder capacity ≤600mL. Furthermore, adjusted analysis confirmed these findings that PVR >250mL and bladder capacity >600mL were associated with a 28% (95%CI [12.1%-43.3%];p<0.01) and 26% (95%CI [13.2%-39%];p<0.01) lower probability of UI at 6 months, respectively.
Conclusions: Adding baseline PVR and bladder capacity assessment to the preoperative evaluation may supplement counseling on protective factors for UI following HoLEP.
期刊介绍:
Urology is a monthly, peer–reviewed journal primarily for urologists, residents, interns, nephrologists, and other specialists interested in urology
The mission of Urology®, the "Gold Journal," is to provide practical, timely, and relevant clinical and basic science information to physicians and researchers practicing the art of urology worldwide. Urology® publishes original articles relating to adult and pediatric clinical urology as well as to clinical and basic science research. Topics in Urology® include pediatrics, surgical oncology, radiology, pathology, erectile dysfunction, infertility, incontinence, transplantation, endourology, andrology, female urology, reconstructive surgery, and medical oncology, as well as relevant basic science issues. Special features include rapid communication of important timely issues, surgeon''s workshops, interesting case reports, surgical techniques, clinical and basic science review articles, guest editorials, letters to the editor, book reviews, and historical articles in urology.